je.st
news
Tag: the
Unable To Compete On Price, Nuclear Power On The Decline In The U.S.
2016-04-08 04:10:23| Energy - Topix.net
The Vermont Yankee nuclear power plant sits along the banks of the Connecticut River in Vernon, Vt. It began operations in 1972 and was shut down at the end of 2014, the victim of competition from plants powered by abundant and cheap natural gas.
Siemens wins $800m contract for Lordstown gas-fired power plant in the US
2016-04-08 01:00:00| Power Technology
Siemens has secured an $800m contract from Clean Energy Future to supply turbines and generators for the proposed natural gas-fired combined cycle power plant (CCPP) in Lordstown, Ohio, US.
Privacy vs. Security: Where Should We Draw the Encrypted Line in the Sand?
2016-04-08 00:59:32| Wireless - Topix.net
The recent Game of Phones between the FBI and Apple underscored an area in our jurisprudence that is screaming for more clarity. If there is a tipping point when the protection of consumer privacy should yield to the needs of a criminal investigation, where is it? Few will dispute the obvious cases where the Constitutional rights of a citizen are disrupted by a judge who knows the legal precedents informing the decision to suspend a citizen's right to privacy .
Tags: the
privacy
line
security
The New Free RN Motion Flyknit Gets the NikeLab Treatment
2016-04-07 23:52:11| Footwear - Topix.net
Nike's Free RN Motion Flyknit made its way to retailers today and, to celebrate, the Swoosh is giving its brand new runner the NikeLab treatment. Making its debut as a part of Nike's Nature of Motion exhibition during Milano Design Week 2016, the make-up sees the low-top with a blacked-out Flyknit upper as grey accents take care of the Swoosh and speckled sole unit.
Tags: the
free
treatment
motion
For J&J Prostate Cancer Is PARP For The Course
2016-04-07 23:45:50| Food - Topix.net
Johnson & Johnson addressed two issues with one relatively small $35m payment: its position in prostate cancer and absence from PARP inhibition. The big pharma group locked up one of just two unpartnered assets in this rejuvenated class and has chosen to focus its work in prostate cancer, where Zytiga might soon run out of market exclusivity.
Tags: the
cancer
prostate
prostate cancer
Sites : [744] [745] [746] [747] [748] [749] [750] [751] [752] [753] [754] [755] [756] [757] [758] [759] [760] [761] [762] [763] next »